Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their employers.

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Between 2018 and 2024, China has launched 188 domestically developed innovative drugs – nearly double the number from the ...